Christopher Garabedian
2011
In 2011, Christopher Garabedian earned a total compensation of $3.9M as President and Chief Executive Officer at Sarepta Therapeutics.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Non-Equity Incentive Plan | $219,201 |
| Option Awards | $2,959,510 |
| Salary | $490,000 |
| Other | $59,099 |
| Total | $3,857,810 |
Garabedian received $3M in option awards, accounting for 77% of the total pay in 2011.
Garabedian also received $130K in bonus, $219.2K in non-equity incentive plan, $490K in salary and $59.1K in other compensation.
Rankings
In 2011, Christopher Garabedian's compensation ranked 1,526th out of 10,747 executives tracked by ExecPay. In other words, Garabedian earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,526 out of 10,747 | 86th |
Division Manufacturing | 562 out of 3,960 | 86th |
Major group Chemicals And Allied Products | 122 out of 1,038 | 88th |
Industry group Drugs | 69 out of 786 | 91st |
Industry Pharmaceutical Preparations | 58 out of 571 | 90th |
Source: SEC filing on April 30, 2013.
Garabedian's colleagues
We found three more compensation records of executives who worked with Christopher Garabedian at Sarepta Therapeutics in 2011.